Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
13.80
|
|
Change (%)
|
0.02 (0.15%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
13.60
-
13.99
|
|
52-Week Range (RS)
|
6.04
-
18.65
|
|
Beta (1 Year)
|
0.79
|
|
|
|
|
|
| Index Details |
| BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Syncom Formulations (India) Ltd - Syncom Formulations (India) Limited - Disclosure under SEBI Takeover Regulations |
| Syncom Formulations (India) Ltd - Syncom Formulations (India) Limited - Updates |
| Syncom Formulations (India) Ltd - Syncom Formulations (India) Limited - Trading Window |
| Syncom Formulations (India) Ltd - Syncom Formulations (India) Limited - Trading Window |
| Syncom Formulations (India) Ltd - Syncom Formulations (India) Limited - Other General Purpose |
| Syncom Formulations (India) Ltd - Syncom Formulations (India) Limited - Updates |
| Syncom Formulations (India) Ltd - Syncom Formulations (India) Limited - Updates |
| Syncom Formulations (India) consolidated net profit rises 69.08% in the December 2023 quarter |
| Syncom Formulations (India) Ltd - Syncom Formulations (India) Limited - Statement of deviation(s) or variation(s) under ... |
| Syncom Formulations (India) Ltd - Syncom Formulations (India) Limited - Copy of Newspaper Publication |
|
|
|
| Incoporation Year : 1988 |
| Chairman : Kedarmal Bankda |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Formulations |
| Registered Office |
Syncom Formulations (India) Ltd
7 Niraj Indl Estate Andheri(E),
Off Mahakali Caves Rd,
Mumbai,
Maharashtra-400093 |
Phone:91-22-30887744
Fax:91-22-30887755 |
| E-Mail : finance@sfil.in; sfil87@syncomformulations.com |
| URL : http://www.syncomformulations.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
19-Apr-2024 |
12.59 |
9.61 |
| 1Month |
26-Mar-2024 |
11.58 |
19.17 |
| 3Month |
29-Jan-2024 |
15.36 |
-10.16 |
| 6Month |
26-Oct-2023 |
8.24 |
67.48 |
| 1Year |
26-Apr-2023 |
6.04 |
128.48 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Motilal Oswal S&P BSE Healthcare ETF |
0.06 |
0.01 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Formulations |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Torrent Pharmaceuticals Ltd |
2,690.45 |
-0.07 |
2,745.55 |
1,599.00 |
91,052.96 |
| Gland Pharma Ltd |
1,729.05 |
-0.55 |
2,195.75 |
861.50 |
28,479.27 |
| Ajanta Pharma Ltd |
2,200.70 |
2.83 |
2,355.05 |
1,240.55 |
27,710.48 |
| ERIS Lifesciences Ltd |
892.60 |
1.21 |
971.00 |
605.20 |
12,143.60 |
| Caplin Point Laboratories Ltd |
1,350.45 |
-0.48 |
1,617.80 |
657.70 |
10,255.55 |
|
|
|
|